160 related articles for article (PubMed ID: 7013978)
21. Nitrosoureas in the management of disseminated malignant melanoma.
Ahmann DL
Cancer Treat Rep; 1976 Jun; 60(6):747-51. PubMed ID: 782696
[TBL] [Abstract][Full Text] [Related]
22. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
23. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
[TBL] [Abstract][Full Text] [Related]
24. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
[TBL] [Abstract][Full Text] [Related]
25. Brain Tumor Study Group: a survey of current activities.
Walker MD
Natl Cancer Inst Monogr; 1977 Dec; 46():209-12. PubMed ID: 148590
[TBL] [Abstract][Full Text] [Related]
26. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
[TBL] [Abstract][Full Text] [Related]
27. [Malignant gliomas treated by combination chemotherapy and delayed radiation therapy (author's transl)].
Poisson M; Pouillart P; Bataini JP; Hauw JJ; Pertuiset BF
Sem Hop; 1981 Feb 8-15; 57(5-6):229-35. PubMed ID: 6259741
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic effect on glioblastoma of chemotherapy on the basis of brain irradiation].
Qin D; Mo H; Ou G
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):168-9. PubMed ID: 11783028
[TBL] [Abstract][Full Text] [Related]
29. Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds.
Paoletti P; Robustelli della Cuna G; Knerich R; Strada MR
Acta Neurochir (Wien); 1978; 41(4):287-99. PubMed ID: 356524
[TBL] [Abstract][Full Text] [Related]
30. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
[TBL] [Abstract][Full Text] [Related]
31. Malignant glioma: who benefits from adjuvant chemotherapy?
DeAngelis LM; Burger PC; Green SB; Cairncross JG
Ann Neurol; 1998 Oct; 44(4):691-5. PubMed ID: 9778271
[TBL] [Abstract][Full Text] [Related]
32. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
[TBL] [Abstract][Full Text] [Related]
33. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of oral methyl-CCNU and prednisone in previously treated alkylating agent-resistant multiple myeloma.
Tornyos K; Silberman H; Solomon A
Cancer Treat Rep; 1977 Aug; 61(5):785-7. PubMed ID: 329977
[TBL] [Abstract][Full Text] [Related]
35. [Role of radiotherapy in recurrent gliomas].
Dhermain F; de Crevoisier R; Parker F; Cioloca C; Kaliski A; Beaudre A; Lefkopoulos D; Armand JP; Haie-Meder C
Bull Cancer; 2004 Nov; 91(11):883-9. PubMed ID: 15582893
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy.
Würschmidt F; Bünemann H; Heilmann HP
Strahlenther Onkol; 1995 Jun; 171(6):315-21. PubMed ID: 7597616
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy for mustard-resistant ovarian adenocarcinoma: a randomized trial for CCNU and methyl-CCNU.
Omura G; DiSaia P; Blessing J; Boronow R; Hreshchyshyn M; Park R
Cancer Treat Rep; 1977 Nov; 61(8):1533-5. PubMed ID: 922756
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of malignant glioma. Apropos of 39 cases].
Louarn F; Brun B; Lebourgeois JP; Djindjian M; Claude C; Barbizet J
Sem Hop; 1983 Feb; 59(7):438-43. PubMed ID: 6302881
[TBL] [Abstract][Full Text] [Related]
39. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]